ERT2-Cre-ERT2 Lentivirus (GATA5 Promoter)
| Cat. No. | LVP010145 |
| Name | ERT2-Cre-ERT2 Lentivirus (GATA5 Promoter) |
| Unit | 3 x 250 µl |
| Description |
ERT2-Cre-ERT2 fusion protein is a tamoxifen-regulated form of Cre recombinase (Cre) fused to a mutant estrogen ligand-binding domain (ERT2). Cre recombinase is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of DNA between loxP sites. The CMV promoter has been removed from pLenti-III and replaced with a GATA5 promoter. This ready-to-use lentivirus is part of abm’s Lentiviral Expression System and can be used to overexpress your gene of interest in a wide range of host cells. Lentiviruses have the ability to integrate into the host genome and generate a stable cell line expressing your gene of interest. |
| Applications |
abm recommends using Cat# G074, Lentifectin™ in conjunction with one of the following packaging mixes. The suggested packaging mix for this vector is Cat# LV003, 2nd Generation Packaging Mix. Alternatively, you can also use Cat# LV053, 3rd Generation Packaging Mix |
| Titer | 107 IU/mL |
| Storage Condition |
Serum-free DMEM with 5% PEG6000 |
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LVP010145 |